BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 36129112)

  • 1. Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
    Lian J; Shi X; Jia X; Fan J; Wang Y; Zhao Y; Yang Y
    J Hypertens; 2023 Jan; 41(1):44-50. PubMed ID: 36129112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between blood pressure and different antihypertensive drugs with outcome after ischemic stroke: A Mendelian randomization study.
    Liu H; Zhang X; Zhou Y; Nguyen TN; Zhang L; Xing P; Li Z; Shen H; Zhang Y; Hua W; Xu H; Zhu X; Chen L; Zuo Q; Zhao R; Li Q; Dai D; Zhang Y; Xu Y; Huang Q; Liu J; Yang P
    Int J Stroke; 2023 Dec; 18(10):1247-1254. PubMed ID: 37337369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the causal relationship between antihypertensive drugs and glioblastoma by combining drug target Mendelian randomization study, eQTL colocalization, and single-cell RNA sequencing.
    Zhao S; Xie Y; Ding X; Zheng C; Chen J; Zhao N; Ji Y; Wang Q; Liu Y; Cheng C
    Environ Toxicol; 2024 Jun; 39(6):3425-3433. PubMed ID: 38450887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of blood pressure and antihypertensive drugs on heart failure: A Mendelian randomization study.
    Li Y; Xiao W; Huang N; Zhuang Z; Zhang L; Wang W; Song Z; Zhao Y; Dong X; Xu M; Huang T
    Nutr Metab Cardiovasc Dis; 2023 Jul; 33(7):1420-1428. PubMed ID: 37156668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically determined blood pressure, antihypertensive medications, and risk of intracranial aneurysms and aneurysmal subarachnoid hemorrhage: A Mendelian randomization study.
    Liu H; Zuo H; Johanna O; Zhao R; Yang P; Chen W; Li Q; Lin X; Zhou Y; Liu J
    Eur Stroke J; 2024 Mar; 9(1):244-250. PubMed ID: 37800876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer's disease: a Mendelian randomization study.
    Ou YN; Yang YX; Shen XN; Ma YH; Chen SD; Dong Q; Tan L; Yu JT
    Alzheimers Res Ther; 2021 Feb; 13(1):41. PubMed ID: 33563324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of beta-blocker and calcium channel blocker antihypertensive drugs in pregnancy: a Mendelian randomization study.
    Ardissino M; Slob EAW; Rajasundaram S; Reddy RK; Woolf B; Girling J; Johnson MR; Ng FS; Gill D
    BMC Med; 2022 Sep; 20(1):288. PubMed ID: 36064525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically predicted hypertension, antihypertensive drugs, and risk of erectile dysfunction: a Mendelian randomization study.
    Zhao C; Feng JL; Deng S; Wang XP; Fu YJ; Wang B; Li HS; Meng FC; Wang JS; Wang X
    Front Cardiovasc Med; 2023; 10():1157467. PubMed ID: 37363097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations.
    Fan B; Zhao JV
    BMC Med; 2024 Jan; 22(1):6. PubMed ID: 38166843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically Predicted Blood Pressure and Risk of Atrial Fibrillation.
    Hyman MC; Levin MG; Gill D; Walker VM; Georgakis MK; Davies NM; Marchlinski FE; Damrauer SM
    Hypertension; 2021 Feb; 77(2):376-382. PubMed ID: 33390040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension, antihypertensive drugs, and age at onset of Huntington's disease.
    Zhu Y; Li M; Bai J; Wang H; Huang X
    Orphanet J Rare Dis; 2023 May; 18(1):125. PubMed ID: 37226269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Mar; 34(3):373-84; discussion 384. PubMed ID: 26780184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing Antihypertensive and Statin Medications for Spinal Pain: A Mendelian Randomization Study.
    Suri P; Elgaeva EE; Williams FMK; Freidin MB; Verzun DA; Tsepilov YA
    Spine (Phila Pa 1976); 2023 Nov; 48(22):1568-1574. PubMed ID: 37539717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of antihypertensive drugs with fracture and bone mineral density: A comprehensive drug-target Mendelian randomization study.
    Huang X; Zhang T; Guo P; Gong W; Zhu H; Zhao M; Yuan Z
    Front Endocrinol (Lausanne); 2023; 14():1164387. PubMed ID: 37056679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
    Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
    PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium, Its Regulatory Hormones, and Their Causal Role on Blood Pressure: A Two-Sample Mendelian Randomization Study.
    Giontella A; Lotta LA; Baras A; Minuz P; Gill D; Melander O; Fava C
    J Clin Endocrinol Metab; 2022 Nov; 107(11):3080-3085. PubMed ID: 36062972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of genetic variants related to combined lipid-lowering and antihypertensive therapies with risk of cardiovascular disease: 2 × 2 factorial Mendelian randomization analyses.
    Li Y; Liu H; Shen C; Li J; Liu F; Huang K; Gu D; Li Y; Lu X
    BMC Med; 2024 May; 22(1):201. PubMed ID: 38764043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure, calcium channel blockers, and the risk of prostate cancer: a Mendelian randomization study.
    Kazmi N; Valeeva EV; Khasanova GR; Lewis SJ; Plotnikov D;
    Cancer Causes Control; 2023 Aug; 34(8):725-734. PubMed ID: 37178364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.